Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand.

Annals of the New York Academy of Sciences - 1 Sept 2001

Kadin M E, Levi E, Kempf W

Abstract excerpt

Our objective is to understand the mechanism of progression of lymphomatoid papulosis (LyP) to CD30+ systemic lymphoma. LyP lesions appear in recurrent crops that regress, only to reappear at a later date in the same or different locations. About 10% of patients develop systemic lymphoma. Because transforming growth factor-beta (TGF-beta) and CD30 ligand inhibit the growth of normal lymphocytes and can be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Ki-1 Antigen
Share to Lymphoma, T-Cell, Cutaneous

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Membrane Glycoproteins

Share to Receptors, Transforming Growth Factor beta

Share to Skin Neoplasms

Share to Transforming Growth Factor beta

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 11594583
DOI: 10.1111/j.1749-6632.2001.tb03711.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand.PMID 11594583Read ↗

Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Semantic proximity Read ↗

Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.Semantic proximity Read ↗

Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell originSemantic proximity Read ↗

Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases.Semantic proximity Read ↗

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.Semantic proximity Read ↗

Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders.Semantic proximity Read ↗

Lymphomatoid papulosis with a natural killer-cell phenotype.Semantic proximity Read ↗

CD30—Governor of Memory T Cells?Semantic proximity Read ↗

A Deletion in the Gene for Transforming Growth Factor β Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor β in a Cutaneous T-Cell LymphomaSemantic proximity Read ↗

A case of lymphomatoid papulosis type E in a young adult: An uncommon entity.Semantic proximity Read ↗

Loss of receptors for transforming growth factor beta in human T-cell malignancies.Semantic proximity Read ↗

The role of p53 and anaplastic lymphoma kinase genes in the progression of cutaneous CD30(+) lymphoproliferative diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.